CASI Pharmaceuticals & BioInvent
1,724
20
2023-5-12 15:28
CASI Pharmaceuticals – executive interview – from EDISON
好好的告个别吧~
手术无菌技术
桡骨创伤入路A部分
Total laparoscopic hysterectomy
骨关节炎
腰椎椎间关节经椎板螺丝钉固定
肝门胆管癌切除术（86例切除经验 1983-1993）
0 bullet chats
Please Sign In first
120101
Scan by WeChatUnauthorized reproduction is prohibited
BioStock interviews BioInvent's CEO Martin Welschof and Wei-Wu He, Chairman & CEO of CASI Pharmaceuticals about their collaboration on BioInvent's propriety asset, the drug candidate and antibody BI-1206.
Comments 0
Please to post a comment~
Loading...
Related Suggestion